Johannes Rolin

Author information from the last article

Johannes Rolin er ph.d., spesialist i barnesykdommer, overlege og medisinsk ansvarlig ved Hormon-, overvekt- og ernæringsavdelingen – seksjon barn og ungdom ved Sykehuset i Vestfold.

Articles by Johannes Rolin

Correction: Supplementary drug treatment to reduce weight in adolescents with severe obesity

Johannes Rolin,
Rønnaug Astri Ødegård,
Viktoria Vedeler Amundsen,
Unni Mette Stamnes Köpp,
Ane Kokkvoll,
Pétur Benedikt Júlíusson,
Jøran Hjelmesæth

12.01.2023: Tidsskr Nor Legeforen 2022; 142: 1250–1. On page 1250 of issue no. 14/2022 of the Journal of the Norwegian Medical Association, the following should be written in the English version of the article: Orlistat (Xenical) is not approved for the treatment of obesity in children aged 12 years or older...

Supplementary drug treatment to reduce weight in adolescents with severe obesity

Johannes Rolin,
Rønnaug Astri Ødegård,
Viktoria Vedeler Amundsen,
Unni Mette Stamnes Köpp,
Ane Kokkvoll,
Pétur Benedikt Júlíusson,
Jøran Hjelmesæth

05.10.2022: In 2021, the Norwegian Medicines Agency approved the use of daily injection of liraglutide 3.0 mg (Saxenda) as a supplement to lifestyle treatment for weight control in children ≥ 12 years of age with obesity (isoBMI ≥ 30). We share the treatment experiences of six multidisciplinary obesity clinics...